William Lipsky
Ophthalmology · Webster, TXNPI 1407850464
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 30.7% of the total. That places this record below the midpoint for ophthalmology clinicians in TX, where the typical reported total is $1,835.
Across 94 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$492
- Mallinckrodt Hospital Products Inc.$218
- Kala Pharmaceuticals, Inc.$108
- Alcon$97
- Novartis$94
- AbbVie$88
- plus $505 from 11 others
Across 16 payments — averaging $24,041 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dompe US, Inc.$139K
- Novartis$119K
- Ocular Therapeutix, Inc.$115K
- Bausch Health US, LLC$12K
What the payments were for
- Food & beverage$1,602100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 28 | $492 |
| Mallinckrodt Hospital Products Inc. | 18 | $218 |
| Kala Pharmaceuticals, Inc. | 5 | $108 |
| Alcon | 5 | $97 |
| Novartis | 6 | $94 |
| AbbVie(2 entities) | 5 | $88 |
| Biotissue Holdings Inc. | 8 | $70 |
| Dompe US, Inc. | 4 | $68 |
| Bausch & Lomb Americas Inc. | 3 | $67 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $67 |
| Carl Zeiss Meditec, Inc. | 1 | $57 |
| Shire North American Group Inc | 3 | $46 |
| Sun Pharmaceutical Industries Inc. | 1 | $36 |
| Sight Sciences, Inc. | 2 | $34 |
| Carl Zeiss Meditec USA, Inc. | 1 | $33 |
| Rxsight Inc | 1 | $15 |
| Akorn, Inc. | 1 | $14 |
How this compares
$1,602 in reported general payments places this provider in the 45th percentile of 1,355 ophthalmology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 18 | $94 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Webster
- Michael SingerSan Antonio$1.8M
- Oluwatosin SmithDallas$1.5M
- Charles WykoffBellaire$1.5M
- John MichelettiHouston$916K
- Davinder GroverDallas$705K
- Christina WengHouston$676K
- Peter ChangHouston$656K
- Zaina Al-MohtasebHouston$636K
- Ashkan AbbeyDallas$559K
- Stephen SladeHouston$530K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.